BD To Announce Financial Results For Its Second Quarter Of Fiscal 2021
News provided by
Share this article
Share this article
FRANKLIN LAKES, N.J., April 5, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its financial results for the second quarter of fiscal year 2021 on Thursday, May 6, 2021. BD will issue a press release detailing the quarter s results, along with related presentation materials posted to www.bd.com/investors, at approximately 6:00 a.m. Eastern Time (ET).
BD management will host a conference call and webcast at 8:00 a.m. ET on May 6. The conference call telephone dial-in number in the U.S. is 800-938-0653. For participants outside the U.S., the dial-in number is 973-935-2408. The confirmation code is: 6334356. The webcast can be accessed through BD s website at www.bd.com/investors and will be available for replay through Thursday, May 13, 2021.
Share this article
Share this article
FRANKLIN LAKES, N.J., April 1, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its rapid antigen test to be used for SARS-CoV-2 screening through serial testing of asymptomatic individuals.
BD today announced the FDA has granted Emergency Use Authorization (EUA) for its BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 to be used for SARS-CoV-2 screening through serial testing of asymptomatic individuals.
An elementary school student is receives a rapid antigen test using the BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2.
Share:
New York, April 01, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Sterile Medical Packaging Market Research Report by Type, by Material, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 - https://www.reportlinker.com/p05993395/?utm source=GNW
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Sterile Medical Packaging Market is expected to grow from USD 39,812.64 Million in 2020 to USD 61,124.87 Million by the end of 2025.
Share this article
Share this article
TUCSON, Ariz., April 1, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it will invest $65 million to construct a state-of-the-art facility in Tucson, Arizona that will be a hub for the company s supply chain, serving as a final-stage manufacturing and sterilization center.
The new 120,000 square-foot facility will be built on approximately 32 acres at the northeast corner of Valencia and Kolb Road and is planned to be operational in mid-2022. BD plans to add approximately 40 new jobs, including engineers, scientists, quality control specialists and other skilled talent. Sun Corridor, Inc. projects that BD s investment will have a $122 million economic impact over the next 10 years.
BD Announces Collaboration with ImageMover for Rapid Antigen Test Reporting
Reporting app helps facilitate SARS-CoV-2 testing and result reporting from BD Veritor™ Plus System
News provided by
Share this article
Share this article
FRANKLIN LAKES, N.J., March 9, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with ImageMover, a software platform that automates and simplifies medical data collection and management, to offer a companion mobile app that enables more streamlined reporting of SARS-CoV-2 antigen testing results performed on the BD Veritor™ Plus System at everyday testing locations, such as schools and businesses. The ImageMover app is available immediately for BD Veritor™ Plus System customers.